RE: Share price21 Dec 2023 22:54
Everyone knows the reviews have been tainted by one or two bitter ex-investors. Boots are well aware of it, the number of reviews is off the scale. Didn't they award Eroxon "new product of the year" or something similar so they don't take the reviews for Eroxon seriously. All the same, the share performance has been abysmal and I thought the directors' recently awarding themselves free shares before they have shown solid sales figures really took the Mickey out of shareholders who have stuck with this. They better come up with some good numbers soon as there seems to be little support, patience running thin on my part anyway.